Preparation and Validation of Iloperidone-hydroxypropyl-β-cyclodextrin Inclusion Compound

HE Hai-yun,HUANG Hua,WANG Hui,TIAN Rui,SHAN Xue-feng
DOI: https://doi.org/10.6039/j.issn.1001-0408.2012.29.18
2012-01-01
Abstract:OBJECTIVE:To prepare and verify Iloperidone-hydroxypropyl-β-cyclodextrin(HP-β-CD) inclusion compound. METHODS:The inclusion compound was prepared by solution-mixing legal system;the inclusion technology was optimized by orthogonal design with inclusion temperature,amount of phosphoric acid,mole ratio of Iloperidone-HP-β-CD and pH value of solution as factors using inclusion rate as index;IR spectrophotometry,differential scanning calorimetry(DSC) ,solubility,phase solubility method were adopted to verify inclusion compound;drug content and inclusion rate were determined by UV spectrophotometry(275 nm) . RESULTS:The optimum inclusion process was as follows:iloperidone ∶ HP-β-CD(mole ratio=1 ∶ 6) ,the inclusion medium was 0.2% phosphoric acid solution,the inclusion temperature was 50 ℃,stirring time was 30 min,and pH value of solution was adjusted to 5.5. The validation showed that the solubility of iloperidone was as 1 950 fold as that of raw material after inclusion complex had been formulated;temperature elevation was conducive to inclusion. The linear range of iloperidone was 2.5~25 μg·mL-1(r=0.999 9) with an average recovery of 99.88%(RSD=1.14%) . The average content of iloperidone in 3 batches of samples was 4.97% with inclusion rate of 98.75%. CONCLUSION:The process of Iloperidone-HP-β-CD inclusion compound is feasible and can increase drug solubility,which provides reference for the development of new formulations.
What problem does this paper attempt to address?